Zynex (ZYXI)
(Delayed Data from NSDQ)
$8.12 USD
-0.21 (-2.52%)
Updated Sep 20, 2024 03:59 PM ET
After-Market: $8.14 +0.02 (0.25%) 7:58 PM ET
4-Sell of 5 4
B Value D Growth D Momentum D VGM
Brokerage Reports
0 items in cart
Zynex Inc. [ZYXI]
Reports for Purchase
Showing records 1 - 20 ( 95 total )
Company: Zynex Inc.
Industry: Medical - Products
2Q24 Financial Results Reported; Reiterate Buy; Lowering PT to $16
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Zynex Inc.
Industry: Medical - Products
Company: Zynex Inc.
Industry: Medical - Products
2023 Financial Results Reported; Reiterate Buy; Adjusting PT to $21
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Zynex Inc.
Industry: Medical - Products
Optimized Entry and Exit Levels for ZYXI 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: Zynex Inc.
Industry: Medical - Products
Company: Zynex Inc.
Industry: Medical - Products
Company: Zynex Inc.
Industry: Medical - Products
FDA Approves CM-1600 Fluid Monitor; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Zynex Inc.
Industry: Medical - Products
Company: Zynex Inc.
Industry: Medical - Products
Preliminary 1Q23 Results Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Zynex Inc.
Industry: Medical - Products
2022 Financial Results Reported; Reiterate Buy: Modulating PT to $20
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Zynex Inc.
Industry: Medical - Products
HCW 2023 Top Picks: Seize the Opportunities
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: Zynex Inc.
Industry: Medical - Products
2022 Preliminary Financial Results Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Zynex Inc.
Industry: Medical - Products
3Q22 Financial Results Reported; Reiterate Buy; Modulating PT to $21
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Zynex Inc.
Industry: Medical - Products
Preliminary 3Q22 Results Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Zynex Inc.
Industry: Medical - Products
Apheresis Clinical Trial Enrolls Patients With CM-1600; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CAUFIELD M
Company: Zynex Inc.
Industry: Medical - Products
Company: Zynex Inc.
Industry: Medical - Products
Company: Zynex Inc.
Industry: Medical - Products
2021 Financial Results Reported; Reiterate Buy; Adjusting PT to $20
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Zynex Inc.
Industry: Medical - Products
Changes in United Healthcare Reimbursement Not Material; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y